Overview

At Bayer we aspire for all women and girls to live well and pursue their ambitions in every aspect of their life. For almost a century, we’ve been committed to make a positive difference to women’s health through pioneering research and innovation. As a global leader in Women’s Health, we work with women and clinicians to understand what really matters and where our expertise can help. We endeavour to provide women with suitable contraception options for each life stage plus a choice of therapies for menopause management and other gynaecological conditions, including relief of heavy menstrual bleeding. Bayer has committed to contributing to the United Nation’s Sustainability goal of increasing access to modern contraception for women through investments in R&D, innovation and supporting community efforts to eliminate access barriers. As part of one of our sustainability initiatives, we have pledged to help 100 million women in low and middle-income countries to access contraception by 2030. Throughout our communication we will refer to the term 'women'. Please note this will cover transmen, non-binary, intersex individuals, along with any others who experience any of the issues discussed. PP-PF-WHC-GB-1183